IntegriChain Deepens Pricing and 340B Advisory Services with Recognized Industry Expert
'The ever-changing regulatory and pricing landscape poses a tremendous challenge to our customers, and nothing is more troublesome than managing the dynamics of the 340B program,' said Bill Roth, Senior Vice President and Managing Partner, Consulting & Advisory of IntegriChain. 'Clay brings decades of industry-proven leadership around these complex issues and will help IntegriChain to deliver even deeper insights as well as decision and operational support.'
'I am excited to join the IntegriChain Advisory team at this pivotal moment,' said Willis. 'Our enhanced Consulting and Advisory services, coupled with IntegriChain's data, technology, and outsourcing capabilities, make IntegriChain ideally suited to address today's drug commercialization challenges. I look forward to helping IntegriChain's customers optimize their revenue and mitigate risk in the complex and dynamic world of 340B, IRA, and other government programs.'
About Clay Willis
Clay will be responsible for expansion of IntegriChain's Government Pricing and Gross to Net Advisory practice, helping companies understand and navigate the dynamic life sciences and healthcare landscape, especially in the areas of 340B Drug Pricing Program ('340B') and impacts to manufacturers from the Inflation Reduction Act of 2022 ('IRA'). Clay's specific expertise is based on a detailed understanding of government programs (Medicaid, Medicare, VA/FSS, 340B) strategy, operations, compliance, and overall channel management. He has knowledge in Government Pricing calculation, gross-to-net optimization, forecasting, and 340B strategies, operations, and self-help related solutions. Most recently, Clay was a Director in Berkeley Research Group's Health Analytics practice where he assisted companies in 340B strategy and operational related matters including helping manufacturers implement 340B Center of Excellence governance and operating models. Previously, Clay held senior-level advisory roles at Deloitte and Huron Consulting where he provided operational, financial, compliance, and strategy related support to small, mid-size, and large pharmaceutical manufacturers. He is a frequent speaker at industry events and is a recognized expert on Government Programs (Medicaid, Medicare, 340B, and VA/FSS) and regulatory dynamics.
About IntegriChain
IntegriChain is the leading provider of revenue optimization technology and insights for the Pharma industry. The company's unique combination of data management, enterprise applications, consulting, and outsourcing helps manufacturers achieve better financial results by connecting commercial execution to net revenue. IntegriChain is backed by Nordic Capital, a leading sector-specialized private equity investor with a broad portfolio in Healthcare and Technology. IntegriChain is headquartered in Philadelphia, PA, with offices in Ambler, PA, and Pune, India. For more information, visit www.integrichain.com or follow on LinkedIn.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Politico
13 minutes ago
- Politico
Final megabill votes are secured, GOP leaders say
Mike Johnson is staring down the legislative challenge of his career. As soon as this morning, the speaker will attempt to ram the Senate-passed megabill through the House as dozens of Republicans threaten to vote it down. The detractors come from across the Republican conference after the Senate sent over a bill with deeper Medicaid cuts, steeper deficit hikes and less onerous clean-energy provisions than expected. And he's gunning to deliver by President Donald Trump's self-imposed July 4 deadline, as severe thunderstorms in Washington threaten full attendance. 'We'll see. I've got to play the cards that are dealt to me,' Johnson said Tuesday, after admitting he was 'not happy' with the Senate's changes to the bill. 'And we're working through that. … But we remain optimistic we're going to land it at this point.' Johnson has 24 to 48 hours to persuade reluctant fiscal hawks and Medicaid moderates to swallow the Senate's bill. He spent Monday on calls with concerned lawmakers and caucuses, scrambling to figure out how to pass it this week without making changes to the bill. (John Thune and Johnson have been in contact through much of the process but did not speak in the hours leading up to the Senate vote, the majority leader told POLITICO.) But the Senate bill will be tough to sell. House Freedom Caucus members like Reps. Chip Roy (R-Texas) and Ralph Norman (R-S.C.) blasted the Senate's bill Tuesday for adding to the deficit and softening clean energy tax credits. Roy and Norman both voted against the bill in the Rules Committee overnight. House moderates are worried about the steep cuts to Medicaid, which Johnson has privately said could cost Republicans the House in 2026. Sen. Thom Tillis' (R-N.C.) speech torching the Senate's Medicaid provisions for similar reasons shook many vulnerable Republicans. And a substantial cross section of the two groups of holdouts would rather take time to rework the package and send it back to the Senate, instead of jamming the Senate version through the House under a self-imposed deadline. Norman said the House should go back to the original bill, leave town and come back when Senate Republicans are 'serious.' Some signs of progress for Johnson: Rep. Nick LaLota (R-N.Y.) appeared more likely to support the bill Tuesday night after previously refusing a deal on a state and local tax deduction. Rep. Jeff Van Drew (R-N.J.), previously a strong no on the bill over the Medicaid provider tax, told POLITICO a local provider tax tweak in the wraparound amendment for New Jersey and other states has him feeling better about the bill. But it would still be a gamble for Johnson to put it on the House floor: Many Republicans think the bill would fail without additional changes. However, the speaker has previously succeeded in putting bills on the floor without the votes — and relying on Trump to pressure holdouts to fold. What else we're watching: — Weather problems could delay House vote: Over 200 flights into Ronald Reagan Washington National Airport were either canceled or delayed Tuesday amid thunderstorms in Washington, according to the flight-tracking service FlightAware. Johnson said Tuesday night that the travel issues could push back the House vote on the GOP megabill, which is expected as early as Wednesday. — More reconciliation packages: As the House looks to pass the current reconciliation package without further tweaks, Johnson is suggesting there could be future opportunities for lawmakers to get their priorities into party-line packages. In an interview on Fox News on Tuesday night, Johnson said the House will plan to do two more reconciliation bills during this session of Congress, which ends in 2026. Jordain Carney, Meredith Lee Hill and Benjamin Guggenheim contributed to this report.
Business Wire
28 minutes ago
- Business Wire
Medimaps Group Launches In Europe TBS Osteo Next-Generation Software For Advanced Bone Microarchitecture Assessment
GENEVA--(BUSINESS WIRE)--Medimaps Group S.A., a global leader in AI-driven bone microarchitecture imaging solutions, announces the European launch of its MDR-cleared next-generation TBS Osteo Advanced software. Following the product launch in the United States last month, this next milestone reflects the company's commitment to advancing osteoporosis detection and bone health management worldwide. TBS Osteo next-generation is available through a convenient subscription model, a flexible option providing customers with eligibility for software updates, new features and support services. Share The TBS Osteo Advanced software delivers refined correction for soft tissue thickness anterior to the lumbar spine, ensuring inclusivity of TBS assessment across a wide range of body phenotypes. It also introduces new system management capabilities, allowing hospitals and healthcare networks to centrally manage the TBS software on their DXA systems fleet, and to standardize workflows across multiple locations. These improvements enhance operational efficiency, streamline clinical processes, and ensure consistent patient care. TBS Osteo is available through a convenient subscription model, a flexible option providing customers with eligibility for software updates, new features and support services. This approach ensures healthcare organizations stay up to date with the latest innovations in osteoporosis care. Current TBS Osteo users have the possibility to upgrade to the next generation version and to take advantage of the new capabilities. 'The TBS Osteo next-generation software has been developed with busy radiology professionals in mind for a maximum of clinical output with a minimum of logistics. The software is seamlessly integrated into the clinical workflow and performed at time of DXA scan. This approach sets TBS Osteo apart from competition,' said Univ. Prof. Dr. Didier Hans, CEO and Co-founder of Medimaps Group. 'TBS Osteo delivers within seconds a comprehensive report combining BMD and clinical factors, providing results beyond the standard of care. Adopted by many top hospitals across the world, including in the U.S., DXA and TBS Osteo have become the gold standard to detect and monitor osteoporosis.' Since its initial launch in 2012, TBS Osteo has been widely adopted across the world, to support the assessment and management of osteoporosis. The software is backed by over 1,400 peer-reviewed publications and endorsed by more than 30 national and international osteoporosis assessment and management guidelines. In Europe, the software has received clearance from the Medical Device Regulation (MDR) and remains the only approved medical software for bone microarchitecture evaluation in clinical practice. Osteoporosis is a condition that weakens bones and increases the risk of fractures. Fractures due to osteoporosis have a devastating impact on millions of people worldwide and result in enormous socio-economic costs to society and healthcare systems. According to the International Osteoporosis Foundation, approximately 32 million Europeans aged 50 or over have osteoporosis. The annual number of osteoporotic fractures across the European Union, Switzerland, and the United Kingdom is projected to rise from 4.33 million in 2019 to 5.34 million by 2034 - an increase of over 1 million fractures annually¹. Despite the availability of effective treatments to reduce fracture risk, only 1 in 5 patients who experience an osteoporotic fracture are diagnosed or receive appropriate therapy¹. References International Osteoporosis Foundation (IOF), Last accessed: June 24, 2025 About Medimaps Group Founded by medical practitioners and clinical researchers, Medimaps combines Swiss innovation with a global presence to lead in bone health management. We provide healthcare professionals worldwide with advanced AI-driven software that enables comprehensive bone microarchitecture assessment. Our passion for musculoskeletal health is underpinned by scientific knowledge, collaborations with world-class academics, clinicians, industry partners, and direct patient engagement. The science behind our cutting-edge imaging applications and clinical evidence forms the core of our company's DNA. Medimaps Group, headquartered in Geneva, Switzerland, has offices in the United States and France. Its U.S. affiliate, Medimaps Group USA LLC, markets the company products and services. Learn more at
Business Wire
an hour ago
- Business Wire
Assetze Introduces ‘EOI', A New IT Model for Global Companies Entering India
BANGALORE, India--(BUSINESS WIRE)--Assetze, an India-based IT asset management company, has supported countless businesses in scaling and running smooth IT operations. Its intuitive SaaS platform enables centralized control and real-time visibility, with companies reporting up to 2x improvement in operational efficiency. Now, Assetze is introducing its latest offering: Employer of IT (EOI). A comprehensive backend model built specifically for companies expanding into India. EOI enables organizations to establish and scale their presence in India while entrusting their entire IT function to Assetze, from infrastructure setup to long-term support and maintenance. Expertise: Whether supporting a fast-growing global startup or an established enterprise, Assetze brings in-depth operational experience to deliver a reliable and compliant IT framework – with experience of serving over 150 companies across the globe. With an on-ground team managing setup, maintenance, and coordination, companies gain a dependable partner for all backend IT operations. Access: Beyond IT management, Assetze also offers Employer of Record (EOR) services, allowing companies to easily establish teams in India. The combination of EOI and EOR gives businesses a complete backend foundation for confidently launching and scaling operations. Results: EOI ensures that IT operations are aligned with security protocols and compliance standards from day one. By eliminating the need for multiple vendors or in-house IT teams, the model simplifies scaling while reducing operational risk and complexity. Several Y Combinator-backed companies already rely on Assetze for IT support, procurement, AI Infra, E-waste, and maintenance services across India. Jagadish V, one of the company's co-founders, expressed, 'Our EOI model has made it effortless for our global clients to establish reliable IT operations in India without building from scratch. It's a new and unique approach to solving a very real problem faced by companies looking to take advantage of India's skilled workforce.'
